Why Pharmaceutical Companies Are Partnering With Contract Manufacturers for Drug Development
Valued at USD 10.07 billion in 2025, the Oral Solid Dosage Contract Manufacturing Market is projected to reach USD 11.02 billion in 2026 and USD 22.62 billion by 2034, growing at a CAGR of 9.4% during the forecast period from 2026 to 2034. Key global CMOs and pharmaceutical service providers shaping technical standards and commercial manufacturing capacity include Catalent, Inc., Lonza Group,...
0 Comments 0 Shares 431 Views 0 Reviews